Cite
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.
MLA
Guptill, Jeffrey T., et al. “Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.” Neurology, vol. 101, no. 10, Sept. 2023, pp. 442–51. EBSCOhost, https://doi.org/10.1212/WNL.0000000000207278.
APA
Guptill, J. T., Benatar, M., Granit, V., Habib, A. A., Howard, J. F., Jr, Barnett-Tapia, C., Nowak, R. J., Lee, I., Ruzhansky, K., Dimachkie, M. M., Cutter, G. R., & Kaminski, H. J. (2023). Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials. Neurology, 101(10), 442–451. https://doi.org/10.1212/WNL.0000000000207278
Chicago
Guptill, Jeffrey T, Michael Benatar, Volkan Granit, Ali A Habib, James F Howard Jr, Carolina Barnett-Tapia, Richard J Nowak, et al. 2023. “Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.” Neurology 101 (10): 442–51. doi:10.1212/WNL.0000000000207278.